Phyto-Riker, an American investor-LED, run a pharmaceutical company in Ghana, considers the consequences of the needs generated by the HIV epidemic in sub-Saharan Africa on its future business plans. In April 2001, it seemed that the political will of the crystallization of the world for their dedication substantial resources to fighting the epidemic. He was not sure that the amount of resources will be available, or how the resources will be spent. At the same time, public health officials, AIDS activists, philanthropists, and pharmaceutical companies have been engaged in various activities aimed at addressing the problem of HIV from their own points of view. "Hide
by John McMillan, Ade Dosunmu Source: Stanford Graduate School of Business 22 pages. Publication Date: January 2, 2002. Prod. #: IB25-PDF-ENG
Related Case Solutions & Analyses:
CBS and Online Video
Malaysia Airlines (B)
UBS and Climate Change–Warming Up to Global Action
Wyeth Pharmaceuticals: Spurring Scientific Creativity with Metrics
Interest Rates Market Pricing and Compounding
BMW: Currency Hedging 2007
Oil Refining in China
Da Clicks Throwback Jerseys
DARTs Suburban Service
International Steel Group
